Segments - Medical Device Contract Manufacturing Market By Type (Device, Services), By Class (Class I, Class II, Class III), By Device Type (IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Endoscopy Devices, Diabetes Care Devices, Personal Care Devices, Ophthalmology Devices, Orthopedic Devices, Dental Devices, Other Devices), By Service Type (Device Development and Manufacturing Service, Quality Management Service, Assembly Service, Other Services), By Application (Oncology, Neurovascular, Urology & Gynecology, Radiology, Cardiovascular, Orthopedic, Others), By Region (North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends and, Forecast 2023 – 2031
The Global Medical Device Contract Manufacturing market was estimated at USD 72,500.0 Million in 2022 and is anticipated to reach USD 163,543.8 Million by 2031, expanding at a CAGR of 9.7% during the forecast period.
The Medical Device Contract Manufacturing (MDCM) market refers to the outsourcing of medical device design, engineering, and manufacturing services to third-party service providers. This market includes various services, such as concept development, prototyping, regulatory consulting, clinical trials, and quality control.
Companies that engage in medical device contract manufacturing to reduce costs, increase efficiency, and accelerate time-to-market for their products. Moreover, they rely on MDCM companies to manage the supply chain, quality control, and regulatory compliance associated with medical device manufacturing.
Medical device contract manufacturers also offer additional services, such as sterilization, testing, and logistics, to provide a complete manufacturing solution for their clients.
Gross domestic product (GDP) is a standard measure of an economic performance of a country, and the medical device contract manufacturing market is influenced by the GDP of the country where it operates. A strong GDP usually leads to an expanding market for medical devices, due to the increased demand from a growing population and a rise in income levels. Consequently, medical device contract manufacturing companies experience an increase in the demand for their services. Economic growth reflected in the GDP has a positive impact on the medical device contract manufacturing market. Increased consumer spending and the demand for healthcare services lead to increasing number of orders and contracts for medical devices.
Regulatory Environment: The medical device industry is heavily regulated, and the compliance with regulations & guidelines is crucial. The regulatory environment varies significantly by country, creating challenges for companies operating in multiple jurisdictions. Trade and Tariffs: Government policies related to trade and tariffs also impact the medical device contract manufacturing market. For instance, in 2021, the Government of India announced a new policy that promotes the use of locally-made medical devices in the healthcare system of the country. The policy aims to reduce its dependence on imported medical devices and promote the growth of the local medical device industry.
The global medical device contract manufacturing market is impacted by the increasing demand for medical devices, due to the rising prevalence of chronic diseases and aging population. The need for advanced and innovative medical devices has escalated in recent years, owing to the growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, and respiratory disorders. This has subsequently led to an increase in the demand for medical device contract manufacturing services to meet the growing demand for these devices. The geriatric population has been steadily increasing globally, leading to a surge in the demand for medical devices to cater to their medical needs. According to the World Health Organization (WHO), the global geriatric population is expected to reach 2.1 billion by 2050, up from 900 million in 2015, creating a significant demand for medical devices.
Advancements in technologies and manufacturing processes have a significant impact on the medical device contract manufacturing market. These advancements have improved the accuracy, precision, and speed of medical device manufacturing, resulting in improved-quality products being produced at low costs. One of the areas where technologies have had the significant impact is in the design and prototyping of medical devices. Computer-aided design (CAD) and computer-aided manufacturing (CAM) technologies have enabled manufacturers to design and test devices quickly and efficiently, reducing the time and cost of product development.
Stringent government regulations and standards have a significant impact on the medical device contract manufacturing market. Governments across the globe have implemented strict regulations and standards to ensure the safety and efficacy of medical devices produced by contract manufacturers. These regulations and standards cover various aspects of medical device manufacturing, including design, development, production, packaging, labeling, and sterilization. One of the significant challenges faced by contract manufacturers in the medical device industry is meeting the regulatory requirements imposed by local and international regulatory bodies.
Increasing investments in healthcare infrastructure in developing countries have had a significant impact on the medical device contract manufacturing market. These countries are increasingly relying on medical device manufacturers to provide the necessary technologies and devices, as they continue to grow and modernize their healthcare systems. This has led to an increase in demand for medical device contract manufacturing services.
Medical device manufacturers have been investing in expanding their facilities and capabilities, as well as forming strategic partnerships and collaborations to meet the increased demand. This has resulted in the access to a greater variety of medical devices and technologies, including advanced surgical equipment, diagnostic devices, and implantable devices, for healthcare providers and patients in the developing countries.
The report on the Global Medical Device Contract Manufacturing Market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Medical Device Contract Manufacturing Market– Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016 and 2020 |
Forecast Period |
2022–2031 |
Segmentation |
By Type (Device, Services), By Class (Class I, Class II, Class III), By Device Type (IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Endoscopy Devices, Diabetes Care Devices, Personal Care Devices, Ophthalmology Devices, Orthopaedic Devices, Dental Devices, Other Devices), By Service Type (Device Development and Manufacturing Service, Quality Management Service, Assembly Service, Other Services), By Application (Oncology, Neurovascular, Urology & Gynaecology, Radiology, Cardiovascular, Orthopaedic, Others), By Region (North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
Biofortuna Limited, Celestica Inc., FLEX LTD., Gerresheimer AG, Integer Holdings Corporation, Invetech, Jabil Inc., MICRO, NIPRO PHARMA CORPORATION, Nordson Corporation, Nortech Systems, Inc., Plexus Corp., Sanmina Corporation., SteriPack Group Ltd, Synecco Ltd, TE Connectivity and Tecomet, Inc. |
Based on type, the global medical device contract manufacturing market is segmented into devices and services. The devices segment is projected to expand at a substantial CAGR during the forecast period, as medical devices help in diagnosis, prevention, monitoring, and treatment of disease. The services segment is expected to hold a significant share of the market during the forecast period, as services are essential to ensure safety, efficacy, and quality of medical devices.
Based on class, the global medical device contract manufacturing market is segmented into Class I, Class II, and Class III. The Class I segment is projected to expand at a substantial CAGR during the forecast period, as devices belonging to this class are low-risk devices with minimal safety considerations. The Class II segment is expected to hold a significant share of the market during the forecast period, as majority of medical devices fall under Class II such as catheters, blood pressure cuffs, and others.
In terms of device type, the global medical device contract manufacturing market is segmented into IVD devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, endoscopy devices, diabetes care devices, personal care devices, ophthalmology devices, orthopedic devices, dental devices, and other devices. The IVD devices segment is projected to expand at a significant CAGR during the forecast period, as these devices help in determining the state of health, in order to cure, mitigate, treat, or prevent a disease.
Based on service type, the global medical device contract manufacturing market is segmented into device development and manufacturing service, quality management service, assembly service, and other services. The device development and manufacturing service segment is projected to expand at a significant CAGR during the forecast period, as this service aids in a wide range of activities from conceptualization to commercialization.
On the basis of application, the global medical device contract manufacturing market is segmented into oncology, neurovascular, urology & gynecology, radiology, cardiovascular, orthopedic, and others. The oncology segment is expected to hold a considerable share of the market, as medical devices help to diagnose, treat, or monitor cancer.
On the basis of region, the global medical device contract manufacturing market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The market in Asia Pacific is projected to expand at a CAGR of 10.3% during the forecast period, owing to the rising burden of chronic disease, growing geriatric population, increasing demand for medical devices, and rapid expansion of the pharmaceutical industry in the region.
Europe holds a significant share of the market in 2022, due to the growing trend of medical device contract manufacturing.
North America accounted for 34.8% share of the market in 2022 and the market in the region is expected to expand at a rapid pace in the coming years. Increasing prevalence of chronic disease, growing demand for medical devices, growing deployment of Industry 4.0, and increasing adoption of technologically advanced medical devices in the region are expected to boost the market during the forecast period. For instance, according to the US Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the key causes of death and disability in the US. Thus, the demand for medical devices that are used to diagnose and treat such conditions is increasing rapidly with the rising burden of chronic diseases.
In July 2023, TE Connectivity opened an In Vitro Diagnostic (IVD) facility in Denver. This facility is expected to design and produce products that enable rapid and accurate diagnosis, personalized treatments, and novel therapies for the diagnostics and life science industries. The new site is anticipated to eventually replace the present facility in Englewood, Colorado, and complements existing facilities that support the design and manufacture of microfluidic devices in Carlsbad, California, and Mondragon, Spain.
In December 2021, Integer Holdings Corporation acquired Oscor Inc., Oscor Caribe, LLC, and Oscor Europe GmbH (collectively ‘Oscor’), privately-held companies with operations in Florida, the Dominican Republic, and Germany that design, develop, manufacture, and market a comprehensive portfolio of highly specialized medical devices, venous access systems, diagnostic catheters, and implantable devices. The acquisition has increased the reach of the company in various geographic locations.
In June 2020, Nordson Corporation acquired Fluortek, Inc. (Fluortek), a precision plastic extrusion manufacturer that provides custom dimensioned tubing to the medical device industry. The acquisition resulted in the rise of its Medical & Fluid solution business segment.
In-depth Analysis of the Global Medical Device Contract Manufacturing Market
Historical, Current, and Projected Market Size in terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints, and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Neutral Perspective on Global Medical Device Contract Manufacturing Market performance
Manufacturers operating in the Global Medical Device Contract Manufacturing Market include Biofortuna Limited, Celestica Inc., FLEX LTD., Gerresheimer AG, Integer Holdings Corporation, Invetech, Jabil Inc., MICRO, NIPRO PHARMA CORPORATION, Nordson Corporation, Nortech Systems, Inc., Plexus Corp., Sanmina Corporation., SteriPack Group Ltd, Synecco Ltd, TE Connectivity and Tecomet, Inc.
Market Players are pursuing key strategies such as acquisitions, collaborations, and geographic expansion where a potential opportunity arises for the Medical Device Contract Manufacturing Market.
Additional company profiles can be provided on request. For a discussion related to the above findings, click Speak to Analyst
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
The Increasing Demand for Medical Devices Due to Rising Prevalence of Chronic Diseases and Aging Population, Advancements in Technologies and Manufacturing Processes, and rising production of Medical Device in the Asia-Pacific Region are the factors driving the growth of the Medical Device Contract Manufacturing Market.
According to this Growth Market Reports report, the Medical Device Contract Manufacturing Market is likely to register a CAGR of XX% during the forecast period 2022-2031, with an anticipated valuation of USD XX Million by the end of 2031.
IVD devices are the major Device Type of medical device contract manufacturing.
Rising GDPs of Emerging Economies, Governmental Regulation, and R&D Activities are expected to act as macroeconomic factors for the market.
Major manufacturers include Biofortuna Limited, Celestica Inc., FLEX LTD., Gerresheimer AG, Integer Holdings Corporation, Invetech, Jabil Inc., MICRO, NIPRO PHARMA CORPORATION, Nordson Corporation, Nortech Systems, Inc., Plexus Corp., Sanmina Corporation., SteriPack Group Ltd, Synecco Ltd, TE Connectivity and Tecomet, Inc.
The contract manufacturing market for medical devices has rebounded with strong demand from customers despite the disruption caused by the COVID-19 pandemic. The strong uptick reflects this in outsourcing providers' merger and acquisition (M&A) activities. Also, as per a 2020 update by the United States Food and Drug Administration (US-FDA), the pandemic triggered an unprecedented demand for medical devices such as ventilators, oxygen concentrators, and COVID-19-related products. Thus, there has been an increase in outsourcing activities for developing medical devices through companies engaged in contract manufacturing.
In addition to market size (in US$ Million) Company Market Share (in % for the base year 2022), Global Medical Device Contract Manufacturing Market: Impact of Key Regulations, Technology Innovation, Current and Future trends for Medical Device Contract Manufacturing Market Outlook, Pricing Analysis & Forecast, 2016-2031.
The base year considered for the Global Medical Device Contract Manufacturing Market report is 2022. The complete analysis period is 2022 to 2031, wherein, 2016, and 2022 are the historic years, and the forecast is provided from 2023 to 2031.